Physician
Roswell Clinic Corp
Roswell Clinic Corp was paid $14.65M by Medicaid between Jan 2018 and Dec 2024, across 148 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 33% of everything it billed.
33Billing provider infoROSWELL CLINIC CORP
ROSWELL, NM 88201
ROSWELL, NM 88201
33aNPI1649267618assigned 10/04/2005
33bProvider typeInternal Medicine Physician
28Total paid$14.65M
24GClaims429,023
24DCodes billed148
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in New Mexico
Rank by total paid#1 of 53
Median peer was paid$93K
This provider vs. median157×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official JACKSON, JENNIFER controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 39,075 | $1.49M | |
| 2019 | 38,912 | $1.81M | |
| 2020 | 34,446 | $1.79M | |
| 2021 | 58,990 | $2.04M | |
| 2022 | 82,572 | $2.17M | |
| 2023 | 96,408 | $2.52M | |
| 2024incomplete | 78,620 | $2.83M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 33% | 62,773 | 56,804 | $4.83M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 56,513 | 52,503 | $3.35M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 6.8% | 11,459 | 11,346 | $996K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 4.9% | 5,192 | 5,121 | $724K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.7% | 5,253 | 5,188 | $690K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 3.0% | 2,049 | 2,013 | $436K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 2.5% | 1,937 | 1,923 | $371K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.2% | 3,066 | 2,628 | $319K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 2.0% | 2,770 | 734 | $297K |
| 90792 | Psychiatric diagnostic evaluation with medical services | 1.8% | 1,929 | 1,843 | $257K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 1.3% | 3,216 | 1,757 | $189K |
| 99238 | Hospital discharge day management, 30 minutes or less | 1.0% | 2,455 | 2,153 | $153K |
136 more codes
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.0% | 3,702 | $151K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 1,529 | $145K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 1,304 | $140K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,025 | $108K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 463 | $99K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 3,987 | $95K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 4,273 | $88K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,158 | $81K |
| 36415 | Collection of venous blood by venipuncture | <1% | 16,744 | $81K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 286 | $75K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 774 | $65K |
| 87428 | <1% | 861 | $60K | |
| 93000 | <1% | 5,046 | $54K | |
| 81025 | <1% | 6,585 | $54K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,331 | $52K |
| 99460 | <1% | 757 | $50K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,823 | $49K |
| 73630 | <1% | 1,769 | $46K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 705 | $41K |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | <1% | 13 | $38K |
| 93458 | <1% | 179 | $35K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 341 | $34K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,617 | $26K |
| 81002 | <1% | 9,114 | $23K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 221 | $23K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 204 | $22K |
| 52000 | <1% | 144 | $19K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 165 | $17K |
| 91200 | <1% | 1,530 | $16K | |
| 93880 | <1% | 671 | $15K | |
| 99442 | <1% | 170 | $14K | |
| 93015 | <1% | 178 | $13K | |
| 69210 | <1% | 395 | $13K | |
| 87807 | <1% | 995 | $13K | |
| 99443 | <1% | 110 | $12K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 115 | $12K |
| 90474 | <1% | 489 | $10K | |
| 92567 | <1% | 822 | $10K | |
| 20610 | <1% | 250 | $9K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 112 | $9K |
| J3490 | Unclassified drugs | <1% | 100 | $9K |
| 51798 | <1% | 884 | $8K | |
| 93297 | <1% | 631 | $7K | |
| 17110 | <1% | 81 | $6K | |
| 99217 | <1% | 101 | $6K | |
| 99225 | <1% | 135 | $6K | |
| 93016 | <1% | 405 | $6K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 166 | $5K |
| 99385 | <1% | 24 | $5K | |
| 73562 | <1% | 191 | $4K | |
| 99219 | <1% | 42 | $4K | |
| 54150 | <1% | 39 | $4K | |
| 31231 | <1% | 17 | $4K | |
| 93018 | <1% | 449 | $4K | |
| 99441 | <1% | 65 | $3K | |
| 99422 | <1% | 45 | $3K | |
| 90688 | <1% | 239 | $3K | |
| 90473 | <1% | 155 | $3K | |
| 90686 | <1% | 665 | $3K | |
| 99223 | Prolong inpt eval add15 m | <1% | 14 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 47 | $2K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 84 | $2K |
| 99454 | <1% | 208 | $2K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 308 | $2K |
| 99220 | <1% | 17 | $2K | |
| 20550 | <1% | 37 | $2K | |
| 99462 | <1% | 48 | $2K | |
| 90670 | <1% | 881 | $2K | |
| 17000 | <1% | 52 | $1K | |
| 99457 | <1% | 157 | $1K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 18 | $1K |
| 90715 | <1% | 43 | $1K | |
| 90656 | <1% | 72 | $1K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 119 | $1K |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 91 | $986.87 |
| 31575 | <1% | 13 | $930.65 | |
| 99221 | <1% | 12 | $849.63 | |
| 46600 | <1% | 12 | $780.51 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 20 | $530.86 |
| 11100 | <1% | 12 | $503.43 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 14 | $434.89 |
| 73564 | <1% | 13 | $431.20 | |
| 73610 | <1% | 12 | $277.91 | |
| 93017 | <1% | 13 | $196.92 | |
| 90633 | <1% | 254 | $155.22 | |
| 90734 | <1% | 17 | $137.09 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 14 | $136.54 |
| 90648 | <1% | 1,208 | $129.17 | |
| 96127 | <1% | 37 | $125.65 | |
| 17003 | <1% | 12 | $120.91 | |
| 90723 | <1% | 1,254 | $120.17 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 15 | $109.69 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 47 | $107.32 |
| 90710 | <1% | 193 | $83.20 | |
| 94060 | <1% | 12 | $81.93 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 43 | $76.72 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 32 | $69.01 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 121 | $68.21 |
| 99453 | <1% | 38 | $55.32 | |
| 81000 | <1% | 26 | $50.12 | |
| 90680 | <1% | 686 | $41.60 | |
| 90651 | <1% | 25 | $41.60 | |
| 1160F | <1% | 7,786 | $41.60 | |
| 90674 | <1% | 45 | $25.93 | |
| 3078F | <1% | 19,986 | $24.70 | |
| 3008F | <1% | 42,853 | $20.80 | |
| 99499 | <1% | 244 | $1.50 | |
| 3075F | 0% | 4,871 | $0.00 | |
| 1126F | 0% | 3,015 | $0.00 | |
| 1034F | 0% | 7,219 | $0.00 | |
| 3079F | 0% | 10,385 | $0.00 | |
| 1036F | 0% | 38,605 | $0.00 | |
| 3074F | 0% | 21,159 | $0.00 | |
| 3080F | 0% | 3,199 | $0.00 | |
| 1123F | 0% | 506 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 1,073 | $0.00 |
| 90677 | 0% | 305 | $0.00 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 250 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 334 | $0.00 |
| 1125F | 0% | 535 | $0.00 | |
| 0500F | 0% | 187 | $0.00 | |
| 1101F | 0% | 53 | $0.00 | |
| 1170F | 0% | 75 | $0.00 | |
| 99024 | 0% | 73 | $0.00 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | 0% | 44 | $0.00 |
| 1035F | 0% | 54 | $0.00 | |
| 0503F | 0% | 27 | $0.00 | |
| 3077F | 0% | 6,813 | $0.00 | |
| 0502F | 0% | 4,180 | $0.00 | |
| 1159F | 0% | 6,084 | $0.00 | |
| 3725F | 0% | 1,285 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 26 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 2,208 | $0.00 |
| 90672 | 0% | 56 | $0.00 | |
| 1090F | 0% | 74 | $0.00 | |
| 3288F | 0% | 60 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJACKSON, JENNIFER (SENIOR DIRECTOR, ENROLLMENT)
Parent organizationROSWELL CLINIC CORP
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.